Publicaciones | IRORESEARCH

Publicaciones y articulos

10/2023 – Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19

Sung Ha Lim, MD; Hyun Jeong Ju, MD, PhD; Ju Hee Han, MD; Ji Hae Lee, MD, PhD; Won-Soo Lee, MD, PhD; Jung Min Bae, MD, PhD; Solam Lee, MD, PhD, Messina Osvaldo Daniel MD, PhD

08/2023 – Patients’ preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study

Charlotte Beaudart, Mitali Sharma, Patricia Clark, Saeko Fujiwara, Jonathan D. Adachi, Osvaldo D. Messina, Suzanne N. Morin, Lynn A. Kohlmeier, Caroline B. Sangan, Xavier Nogues, Griselda Adriana Cruz Priego, Andrea Cavallo, Fiona Cooper, Jamie Grier, Carolyn Leckie, Diana Montiel-Ojeda, Alexandra Papaioannou, Nele Raskin, Leonardo Yurquina, Michelle Wall, Olivier Bruyère, Annelies Boonen, Elaine Dennison, Nicholas C.Harvey, John A. Kanis, Jean-François Kaux, E. Michael Lewiecki, Oscar Lopez-Borbon, Zoé Paskins,Jean-Yves Reginster, Stuart Silverman, Mickael Hiligsmann

10/2023 – Toxicidades reumatológicas secundarias al uso de inhibidores de punto de control inmunitario.

Garbarino Cecilia, Manzano Natalia, Messina Osvaldo, Zylberman Marcelo

10/2023 – El viaje del paciente con fibromialgia en Latinoamérica

Teresa Otóna, Osvaldo Daniel Messina, Daniel G. Fernández Ávila, Manuel Robles San Román, Andrea Carvallo, Constanza Arguissain, Jorge Miguel Galindo Guzmán, Marina Pérez, Loreto Carmona y Grupo Fibrojourney Latam

08/2023 – Obesity, osteoporosis and fractures

Barcelona, España

08/2023 – La elección del mejor calcio en el manejo de la osteoporosis: ¿dietético o farmacológico?

Franklin José Espitia De La Hoz, José Luis Neyro y Daniel Osvaldo Messina

05/2023 – SEFIFAC

SOCIEDAD ESPAÑOLA DE FIBROMIALGIA Y SÍNDROME FATIGA CRÓNICA

05/2023 – Chronic arthritides and bone structure: focus on rheumatoid arthritis—an update

Osvaldo Daniel Messina, Maritza Vidal, Giovanni Adami, Luis Fernando Vidal, Patricia Clark, Jorge Morales Torres, William Lems, Cristiano Zerbini, Constanza Arguissain, Jean‑Yves Reginster, Nancy Lane.

09/2022 – Eventos adversos reumatológicos secundarios al uso de inhibidores de punto de control inmunitario

María Cecilia Garbarino, Natalia Manzano, Osvaldo Messina y Marcelo Zylberman.

08/2018 – Denosumab versus risedronate in glucocorticoid-induced osteoporosis

11/2019 – Denosumab Versus Risedronate in Glucocorticoid-I nduced Osteoporosis

03/2023 – Research Gate

01/2022 – Vitamina D en enfermedades Reumáticas

01/2022 – El concepto de la Reumatología

El Dr. reumatólogo, Osvaldo Daniel Messina, habló con Claudio Zin y equipo, en Salud 630. Sobre su especialidad como reumatólogo y que significa.

12/2015 – The Discriminatory Ability of the Fibromyalgia Rapid Screening Tool

Antonio Collado, Xavier Torres, Osvaldo D. Messina, Luis F. Vidal, Patricia Clark, Carlos R, Emılia Sole, Anna Arias, Serge Perrot and Patricia A. Salomon

11/2022 – Evidence based Latin American Guidelines of clinical practice on prevention, diagnosis, management and treatment of glucocorticoid induced osteoporosis. A 2022 update

Osvaldo Daniel Messina1 · Maritza Vidal · Jorge A Morales Torres · Luis Fernando Vidal · Constanza Arguissain · Rosa María Pereira · Patricia Clark · Sonia Cerdas Perez · Claudia Campusano · Marise Lazaretti‑Castro · Cristiano Zerbini · Juan J. Scali · Lucia Mendez Sanchez · Maria L. Peralta‑Pedrero · Andrea Cavallo · Francisco J. Valdivia Ibarra · Talina Hernandez Pérez

06/2021 – Refractory fibromyalgia

Luis F. Vidal · Osvaldo Messina · Tamara Rodríguez · Maritza Vidal · Carlos Pineda · Rasec Morales · Antonio Collado

02/2021 – Management of glucocorticoid‑induced osteoporosis

Osvaldo D. Messina · Luis Fernando Vidal · Maritza Vidal Vidal · Irene E. M. Bultink · Hennie G. Raterman · William Lems

01/2021 – Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis to methotrexate the phase 3

René Westhovens, William F C Rigby, Désirée van der Heijde, Daniel W T Ching, William Stohl, Jonathan Kay, Arvind Chopra, Beatrix Bartok, Franziska Matzkies, Zhaoyu Yin, Ying Guo, Chantal Tasset, John S Sundy, Angelika Jahreis, Neelufar Mozaffarian, Osvaldo Daniel Messina, Robert BM Landewé, Tatsuya Atsumi, Gerd R Burmester

08/2022 – Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3)

Tatsuya Atsumia, Yoshiya Tanaka, Tsukasa Matsubarac, Koichi Amanod, Naoki Ishiguroe, Eiji Sugiyamaf, Kunihiro Yamaoka, Reń e Westhovensh, Daniel W.T. Chingi, Osvaldo Daniel Messinaj, Gerd R. Burmesterk, Mark Genovesel, Beatrix Bartokl, Alena Pechonkinal, Akira Kondom, Zhaoyu Yinl, Qi Gongl, Chantal Tassetn and Tsutomu Takeuchio

04/2018 – Saag Dmab vs RIS in GIO 2018 Lancet Endocrinol

Kenneth G Saag, Rachel B Wagman, Piet Geusens, Jonathan D Adachi, Osvaldo D Messina, Ronald Emkey, Roland Chapurlat, Andrea Wang, Nicola Pannacciulli, Willem F Lems

09/2019 – Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures.

J. A. Kanis & N. C. Harvey & E. McCloskey & O. Bruyère & N. Veronese & M. Lorentzon & C. Cooper & R. Rizzoli & G. Adib & N. Al-Daghri & C. Campusano & M. Chandran & B. Dawson-Hughes & K. Javaid9 & F. Jiwa & H. Johansson & J. K. Lee & E. Liu & D. Messina & O. Mkinsi & D. Pinto & D. Prieto-Alhambra & K. Saag & W. Xia & L. Zakraoui & J. -Y. Reginster

04/2019 – Nutrition, osteoarthritis and cartilage metabolism.

Osvaldo Daniel Messina & Maritza Vidal Wilman & Luis F. Vidal Neira

12/2018 – Osteoporosis: a clinical and pharmacological update.

Maritza Vidal & Ross J. Thibodaux & Luis Fernando Vidal Neira & Osvaldo Daniel Messina

08/2018 – Osteoporosis prevention and treatment in Latin America — current structure and future directions

Maritza Vidal & Ross J. Thibodaux & Luis Fernando Vidal Neira & Osvaldo Daniel Messina

04/2018 – EVOLUCIÓN Y OSTEOARTRITIS.

L. F. Vidal Neira, O. D. Messina

03/2018 – INMUNOTERAPIA EN CANCER. LO QUE DEBE SABER EL REUMATOLOGO.

S. Rivero, M. Zylberman, O. D. Messina

12/2017 – FRAX-based intervention and assessment thresholds in seven Latin American countries.

P. Clark, E. Denova-Gutiérrez, C. Zerbini, A. Sanchez, O. Messina, J. J. Jaller, C. Campusano, C. H. Orces, G. Riera, H. Johansson, J. A. Kanis

09/2016 – Biologic therapies and bone loss in rheumatoid arthritis.

C. A. F. Zerbini & P. Clark & L. Mendez-Sanchez & R. M. R. Pereira & O. D. Messina & C. R. Uña & J. D. Adachi & W. F. Lems & C. Cooper & N. E. Lane

04/2011 – DIAGNÓSTICO Y TRATAMIENTO FARMACOLÓGICO Y NO FARMACOLÓGICO DE LA FIBROMIALGIA.

P. Clark, M.J. Gentile, M. Helfenstein, M.J. Jannaut, V. Liendo, C. Ríos, L. Vidal Neira, O.D. Messina

Premios

01/2019 – WILEY: TOP DOWNLOADED PAPER 2018-2019 – Arthritis & Rheumatology.

O. D. Messina

Diseño y Desarrollo: BGGD design